Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual Disease

In our single center retrospective study of day 14 bone marrow assessment in AML, we found cellularity to be a stronger predictor of response than blast percentage or receipt of re-induction chemotherapy. For patients with blast percent and cellularity. Induction chemotherapy for acute myeloid leuke...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2018-03, Vol.18 (3), p.204-209
Hauptverfasser:	Ollila, Thomas A., Olszewski, Adam J., Butera, James N., Quesenberry, Matthew I., Quesenberry, Peter J., Reagan, John L.
Format:	Artikel
Sprache:	eng
Schlagworte:	AML Blood Cell Count - methods Cellularity Day-14 bone marrow biopsy Female Humans Hypocellular Induction Chemotherapy - methods Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - pathology Male Prognosis Residual leukemia Retrospective Studies Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!